The Proposal to Lower P Value Thresholds to .005https://t.co/GKKNYXilzP
— Biotech Radar (@BiotechRadar) March 22, 2018
A new way of thinking about tau kinetics, an essential component of #Alzheimer's diseasehttps://t.co/iC0NRwmDMd
— Andy Biotech (@AndyBiotech) March 27, 2018
Very interesting proteomic analysis on tauhttps://t.co/04cUdgieWT$BIIB $ACIU $ABBV $VYGR $PRTA $CELG pic.twitter.com/jLMEwcCcGu
cute trick: antibodies that "lock" but don't block
— Paul D. Rennert (@PDRennert) March 30, 2018
keeping NK triggering proteins locked on the surface of tumor cellshttps://t.co/aE8pibRXZihttps://t.co/VsWyAVE2N8
Excellent collection of #OpenAccess papers from the Pan-Cancer Atlas https://t.co/3Ibai0JREN
— Andy Biotech (@AndyBiotech) April 6, 2018
Super helpful resource esp for those interested in target therapieshttps://t.co/lbx9Ak2Rgkhttps://t.co/sxMCqYmL4O$LOXO $RXDX $BPMC $DCPH $KURA $SPPI $ARRY $ARQL $INCY pic.twitter.com/FHzQ8k79Yd
Merck researchers determine 4.3Å #cryoEM structure of insulin receptor in complex with insulin https://t.co/azjwGzNvxa pic.twitter.com/GT6RtmiJT8
— Peter Nollert (@reducentropy) April 7, 2018
The remarkable heterogeneity for life expectancy, disease burden, morbidity throughout the United States @JAMA_current https://t.co/SANi5OfvK0 #OA @IHME_UW pic.twitter.com/2BNmE1vHtX
— Eric Topol (@EricTopol) April 10, 2018
The FDA Breakthrough-Drug Designation — Four Years of Experience | NEJM https://t.co/U4ivRLBbq0
— Pierre Bedard (@PRB51) April 12, 2018
Original Article: Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma (KEYNOTE-054) https://t.co/G0VH9LRejc #AACR18 pic.twitter.com/QJh0FA4B6F
— NEJM (@NEJM) April 15, 2018
Original Article: Nivolumab plus Ipilimumab in High Tumor Mutational Burden Lung Cancer (CheckMate 227) https://t.co/ap1wmk4Vwg #AACR18 pic.twitter.com/fy1jTJ82vX
— NEJM (@NEJM) April 16, 2018
Day 3 of #AACR18 and here are two reviews on platforms for anticancer therapy - microRNA-based therapies https://t.co/gjBFeTAWZb and antibody-drug conjugates https://t.co/Wb6JhM2Fni pic.twitter.com/6swqh5CuIE
— Nature Rev Drug Disc (@NatRevDrugDisc) April 16, 2018
Gene therapy prevails again: transfusion-dependent β-thalassemia achieving cures in place of allogenic donor transplanthttps://t.co/NUmdxsF0CW @NEJM by @DrAlexisThompsn and colleagues pic.twitter.com/ZDgCNvFZsL
— Eric Topol (@EricTopol) April 18, 2018
A Multiscale View of Inborn Errors or Metabolism - great example of how supposedly simple "Mendelian" disorders actually show complex genetic inheritance #epistasishttps://t.co/K1lU8dcANp pic.twitter.com/Fjk6knundB
— Kevin Mitchell (@WiringTheBrain) April 20, 2018
RSS Feed
